In this episode of “No Small Plans,” we sit down with Strand Therapeutics cofounder and CEO, Jacob Becraft; cofounder and head of R&D, Tasuku Kitada; and chief operating officer Samta Kundu.

Strand Therapeutics, founded in 2017, makes mRNA therapies safer and more effective by programming the location, timing, and intensity of therapeutic protein expression inside a patient’s body using mRNA-encoded logic circuits. These circuits can implement cell-type specific expression by sensing and classifying the unique miRNA expression signatures of cells, as well as controlling the dosage of protein expression by responding to exogenously administered small molecules. It's the world’s first platform for mRNA smart therapies.